Tesamorelin (5mg) / Ipamorelin (5mg)
This research formulation contains:
-
Tesamorelin (5mg) – CAS: 218949-48-5
-
Ipamorelin (5mg) – CAS: 170851-70-4
These peptides are commonly studied in vitro for their roles in growth hormone-releasing activity and selective receptor targeting. This blend provides a structured combination for experimental pathway analysis.
Form: Lyophilized Powder
Storage: Store at -20°C
For Laboratory Research Use Only. Not for human consumption or therapeutic use.
